Multiple Myeloma: Clinical Trials

1 trial for Multiple Myeloma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Enrolling by invitation 1

Follow Multiple Myeloma: new trials by email Literature Review of Multiple Myeloma trials Research Report on Multiple Myeloma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
TempTraq, VitalTraq - Cytokine Release Syndrome, Neoplasms
Not applicableEnrolling by invitationNational Cancer Institute (NCI)1362026-05-272026-06-25

Narrower conditions

Cytokine Release Syndrome (1)  ·  Lymphoma (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Inflammation (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

Nicholas P Tschernia, M.D. (1)